In the last trading session, 14,337,383 Atossa Therapeutics, Inc. (NASDAQ:ATOS) shares changed hands as the company’s beta touched 2.15. With the company’s per share price at $5.89 changed hands at $0.54 or 0.1% during last session, the market valuation stood at $711.65 Million. ATOS’s last price was a discount, traded about -15.79% off its 52-week high of $6.82. The share price had its 52-week low at $0.81, which suggests the last value was 86.25% up since then. When we look at Atossa Therapeutics, Inc.’s average trading volume, we note the 10-day average is 13.84 Million shares, with the 3-month average coming to 13.57 Million.
Analysts gave the Atossa Therapeutics, Inc. (ATOS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2. If we narrow down to specifics, the data shows that none out of 2 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, none recommended ATOS as a Hold, 2 felt it is a Buy and none rated the stock as Underweight. Atossa Therapeutics, Inc.’s EPS for the current quarter is expected to be -$0.03.
Atossa Therapeutics, Inc. (NASDAQ:ATOS) trade information
The consensus price target for the stock as assigned by Wall Street analysts is $7.5, meaning bulls need an upside of 27.33% from its current market value. According to analyst projections, ATOS’s forecast low is $7 with $8 as the target high. To hit the forecast high, the stock’s price needs a +35.82% upsurge from its current level, while the stock would need to tank 18.85% for it to hit the projected low.
Atossa Therapeutics, Inc. (ATOS) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 52.4%. The 2021 estimates are for Atossa Therapeutics, Inc. earnings to increase by 2.7%, but the outlook for the next 5-year period is at 0% per year.
Atossa Therapeutics, Inc. (NASDAQ:ATOS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.04% of Atossa Therapeutics, Inc. shares while 12.09% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 12.09%. There are 57 institutions holding the Atossa Therapeutics, Inc. stock share, with Renaissance Technologies, LLC the top institutional holder. As of Mar 30, 2021, the company held 2.73% of the shares, roughly 3.3 Million ATOS shares worth $6.97 Million.
Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 2.63% or 3.18 Million shares worth $6.71 Million as of Mar 30, 2021.
Among Mutual Funds, the top two as of Mar 30, 2021 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 2080920 shares estimated at $4.39 Million under it, the former controlled 1.72% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.83% of the shares, roughly 1Million shares worth around $2.11 Million.